Your Health. Your Family. Your Choice.
Administered by: Other Purchased by: Other
Life Threatening? No
Write-up: This case was reported by a physician and described the occurrence of erythematous rash in unspecified number of patients who received BEXSERO. On an unknown date, the patients received BEXSERO at an unknown dose. On an unknown date, several days after receiving BEXSERO, the patients experienced erythematous rash. On an unknown date, the outcome of the erythematous rash was unknown. It was unknown if the reporter considered the erythematous rash to be related to BEXSERO. Additional details were provided as follows: The reported stated about several reports of bilateral erythematous rash presenting on both upper deltoids of an unspecified number of patients within days after vaccination with BEXSERO. This case has been linked to case US2016GSK019838.
Copyright © 2022 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166